CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 147 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| US BANCORP \DE\ | 119 | $3,275 | 0.00% |
| Parallel Advisors, LLC | 22 | $605 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 392 | $10,788 | 0.00% |
| WELLS FARGO & COMPANY/MN | 41,829 | $1,151,134 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UMB Bank, n.a. | 2 | $55 | 0.00% |
| First Horizon Advisors, Inc. | 333 | $9,164 | 0.00% |
| Legal & General Group Plc | 40,844 | $1,124,050 | 0.00% |
| NOMURA ASSET MANAGEMENT CO LTD | 0 | $0 | 0.00% |
| JANUS HENDERSON GROUP PLC | 17,020 | $468,307 | 0.00% |
| CANADA LIFE ASSURANCE Co | 3,615 | $99 | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 1,240 | $34,125 | 0.00% |
| STRS OHIO | 1,400 | $38 | 0.00% |
| Fisher Asset Management, LLC | 20,538 | $565,205 | 0.00% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 34,868 | $959,567 | 0.00% |
| ROYAL BANK OF CANADA | 7,768 | $214,000 | 0.00% |
| Invesco Ltd. | 37,135 | $1,021,955 | 0.00% |
| Hartford Financial Management Inc. | 18 | $496 | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 368 | $10,072 | 0.00% |
| WOLVERINE TRADING, LLC | 12,400 | $341,248 | 0.00% |
External links
This page lists CELLDEX THERAPEUTICS INC NEW's shareholders in Q3 2023. To view CELLDEX THERAPEUTICS INC NEW's shareholder history, click here.